April Hansen
Women's Health · New York, NYNPI 1649984105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Genmab U.S., Inc. at 28.7% of the total. Among women's health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genmab U.S., Inc.$621
- Merck$304
- AstraZeneca$244
- GSK$212
- Novartis$170
- EMD Serono, Inc.$89
- plus $522 from 14 others
What the payments were for
- Food & beverage$2,06395%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genmab U.S., Inc. | 30 | $621 |
| Merck | 14 | $304 |
| AstraZeneca(2 entities) | 7 | $244 |
| GSK | 10 | $212 |
| Novartis | 8 | $170 |
| EMD Serono, Inc. | 3 | $89 |
| Blueprint Medicines Corporation | 2 | $68 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Eisai Inc. | 3 | $61 |
| Rigel Pharmaceuticals, Inc. | 2 | $52 |
| Napo Pharmaceuticals Inc | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Foundation Medicine, Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Gilead | 1 | $24 |
| Bayer | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
How this compares
$2,162 in reported general payments places this provider in the 90th percentile of 376 women's health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 12 | $147 |
| Prochlorperazine Maleate | 16 | $112 |
Paid to pharmacies, not to this prescriber.
Other women's health in New York
- Austin JacobusNew York$51K
- Stacy GarrityNew York$5K
- Sarah WeldNew York$5K
- Kathleen CsillagNew York$5K
- Cyma MounzerNew York$3K
- Natisha ChenNew York$2K
- Eileen PerryNew York$2K
- Suzanna MarksteinNew York$2K
- Toniann PrivrackyNew York$2K
- Rebecca CallahanNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.